Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-476-5
CAS number: 85535-84-8
C10-13 chlorinated paraffins (of varying chain length and degree of chlorination) are of very low acute toxicity in animal studies, with some signs of systemic toxicity seen in rats and mice administered oral doses of 13 and 27 g/kg bw, respectively, but no signs of systemic toxicity in rats following 1 h exposure to vapours of 3.3 g/m3 and greater or with a dermal dose of 2.8 g/kg bw. Acute LD50s of greater than 4 and 2.8 g/kg bw following oral and dermal exposures, respectively, and LC50s of more than 3300 mg/m3 (3.3 mg/L), have been reported.
No relevant human data is currently
Acute oral toxicity
In good quality NTP studies, groups of
F344/N rats and B6C3F1 mice (5/sex/dose) were given single doses of a
C12 chlorinated paraffin (60% chlorination) by stomach tube and observed
for abnormal clinical signs twice daily for up to 15 days. The
chlorinated paraffin was administered in corn oil at dose levels of 816,
1632, 3400, 6800 and 13,600 mg/kg bw in rats and of 1632, 3264, 6800 and
13,600 mg/kg bw at a dose volume of 20 ml/kg and at 27,200 mg/kg bw
undiluted in mice. No deaths were observed at any dose during the study
period. All animals were inactive and ataxic after dosing. In rats,
diahrroea was seen in all males and all but the lowest dose females
lasting between 2 and 6 days. Ruffled fur was seen in all mice on days 2
to 6 after dosing (NTP, 1986).
As summarised in the final RAR (EU, 2000),
several other studies have been conducted on C10-13 paraffins which were
40 to 70% chlorinated. In all of these studies groups of three male and
three female rats were treated by gavage with a range of maximum doses
of 4 to 13 g/kg bw chlorinated paraffin (containing up to 5% epoxy
stabilisers with various additives). Rats were observed for 7 days after
treatment when macroscopic examinations were conducted. With the
exception of one study, no deaths occurred. The death occurred in one
rat treated with 13 g/kg bw with a 63% chlorinated paraffin (ICI, 1974).
Signs of toxicity in the moribund and surviving animals were also more
extreme in this study and included coma, laboured breathing and tremors.
Signs of toxicity in the majority of studies occurred with the lowest
doses tested, from approximately 2 g/kg, and included piloerection,
urinary incontinence and lethargy. Recovery, when reported, was usually
complete by day 7. Macroscopic examination revealed "minimal signs of
stress" in the spleen (with a 50% chlorinated paraffin, unpublished
reference 59, 1968), blotchy or pale liver with slight fatty changes and
inflamed stomach (with 69 and 40% chlorinated paraffin, unpublished
references 61, 1965 and 57, 1966). Overall, the chlorinated paraffins
tested were of very low oral toxicity following a single dose and the
intensity and nature of those effects that were observed were
independent of degree of chlorination.
According to a published paper (Birtley et
al. 1980), which summarises several or all of the studies mentioned
above, groups of 3 or more male and/or female Wistar rats were given
single doses of various C10 -13 chlorinated paraffins (with extent of
chlorination varying from 41 to 70%) by stomach tube and observed for
abnormal clinical signs for up to 14 days. At the end of this
observation period, animals were autopsied and selected tissues/organs
were examined histologically and microscopically. Dose levels of
chlorinated paraffins used varied from 0.5 to 10 g/kg bw, administered
with or without a vehicle such as olive oil. A total of 14 experiments
were carried out with the C10 -13 chlorinated paraffins. No mortalities
were observed for any of the tested chlorinated paraffins, although
various abnormalities were noted, including certain adverse clinical
signs (piloerection, muscular incoordination and urinary/fecal
incontinence) and histopathological changes (including hepatocellular
vacuolation and focal necrosis in the liver and cloudy swelling of inner
cortical cells in the kidneys). It was noted that the toxic effects were
slight and that the clinical signs generally disappeared within 7 days.
The limitations in reporting do not allow the observed effects to be
attributed to any specific chlorinated paraffin sample or to ascertain
at what dose level(s) the effects occurred. However, the acute oral LD50
in these studies is reported to be greater than 4 g/kg bw.
Acute inhalation toxicity
Cereclor 50 HS (a 50% chlorinated,
short-chain paraffin; presumably C10-13) was tested for acute inhalation
toxicity in rats at a vapour concentration of 48.17 g/m3 for 1 h. No
deaths were reported and only slight nose and eye irritation were seen.
Recovery occurred "soon" after exposure and remained normal throughout
the [unspecified] observation period. The 1 h acute inhalation LC50 for
Cereclor 50 HS is greater than 48.17 g/m3 (48.17 mg/L).
and no other signs of toxicity were observed in rats exposed to air
containing Chlorowax 500C (a C12 chlorinated paraffin; 59% chlorination)
at 3300 mg/m3 (3.3 mg/L) for 1 h, therefore the 1 h acute inhalation
LC50 value can be considered as greater than 3300 mg/m3 (3.3 mg/L). No
further details are given in an early US EPA review (Howard et al. 1975)
apparently citing a personal communication with industry (Diamond
Shamrock Chem. Co. 1975), or in the final RAR on SCCPs (EU, 2000).
According to the final RAR on SCCPs (EU,
2000), a C10-13 chlorinated paraffin (52% chlorination) was tested for
acute dermal toxicity at 2.5 ml/kg bw (about 2.8 g/kg bw) in an
well-conducted study (ICI, 1971). When applied undiluted, under an
occlusive dressing, to groups of 3 rats for 24 h, local signs of
irritation (slight erythema and slight slight desquamation) were seen at
the application site at 3 and 7 days post-application. No deaths or
other signs of systemic toxicity were reported in the treated rats. The
acute dermal LD50 of this C10-13 chlorinated paraffin can be considered
as greater than 2.5 ml/kg bw (about 2.8 g/kg bw).
The acute dermal LD50 value for Chlorowax
500C (a C12 chlorinated paraffin; 59% chlorination) was reported to be
greater than 10 ml/kg bw (approximately 13.5 g/kg bw) in the rabbit. The
test material was apparently applied occluded for 24 h, and the animals
observed for 14 days. No further details are given in an early US EPA
review (Howard et al. 1975) apparently citing a personal communication
with industry (Diamond Shamrock Chem. Co. 1975),
or in the final RAR on SCCPs (EU, 2000).
References (for which no ESR has been
created - please move to reference list in CSR)
ICI (1974). ICI
CLT/T/962, 01.12.74 (cited in EU, 2000).
The acute oral LD50 of various C10 -13
chlorinated paraffins (40 -70% chlorination) is reported to be greater
than 4 g/kg bw, the acute LC50 of two C10-13 chlorinated paraffins (50
and 59% chlorination) was more than 3300 mg/m3 (3.3 mg/L), and the acute
dermal LD50 of two C10-13 chlorinated paraffins (52 and 59%
chlorination) can be considered as greater than 2.5 ml/kg bw (about 2.8
g/kg bw). Therefore, under the condiions of these studies, SCCPs would
not be classified as acutely toxic by any route of exposure according to
EU CLP or DSD regulations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Ta stran uporablja piškotke za zagotavljanje najboljše možne uporabniške izkušnje na našem spletišču.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again